The cash flow of ABBOTT LABORATORIES over the past 10 years
Chart ABBOTT LABORATORIES: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, ABBOTT LABORATORIES's operating cash flow was $9.57B and its capital expenditures $2.17B, leaving free cash flow of $7.39B. Free cash flow was above zero in all 10 years shown. It ranged from $2.08B in fiscal 2016 to $8.65B in fiscal 2021. Capital expenditures were highest in fiscal 2024, at $2.21B.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $9.57B | $2.17B | $7.39B |
| 2024ended Dec 31, 2024 | $8.56B | $2.21B | $6.35B |
| 2023ended Dec 31, 2023 | $7.26B | $2.2B | $5.06B |
| 2022ended Dec 31, 2022 | $9.58B | $1.78B | $7.8B |
| 2021ended Dec 31, 2021 | $10.53B | $1.89B | $8.65B |
| 2020ended Dec 31, 2020 | $7.9B | $2.18B | $5.72B |
| 2019ended Dec 31, 2019 | $6.14B | $1.64B | $4.5B |
| 2018ended Dec 31, 2018 | $6.3B | $1.39B | $4.91B |
| 2017ended Dec 31, 2017 | $5.57B | $1.14B | $4.43B |
| 2016ended Dec 31, 2016 | $3.2B | $1.12B | $2.08B |
Fiscal years as ABBOTT LABORATORIES reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ABBOTT LABORATORIES
- The revenue of ABBOTT LABORATORIES
- The profitability of ABBOTT LABORATORIES
- The debt of ABBOTT LABORATORIES
- The dividends of ABBOTT LABORATORIES
- All of ABBOTT LABORATORIES's financials, charted
Companies of a similar size
Not investment advice. This page shows what ABBOTT LABORATORIES filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.